Luisa Rubinelli
Research Subjects
Luisa Rubinelli has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Annarita Di Lorenzo
Department of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA
3 shared publications - Alice Marino
Pôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain , Av. Hippocrate 55, Brussels 1200
2 shared publications - James E. Ip
Department of Medicine, Division of Cardiology, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York
2 shared publications - Yi Zhang
Department of Pathology and Laboratory Medicine
2 shared publications - Chul-Hee Lee
Molecular Imaging Innovations Institute and Department of Radiology
1 shared publication - James M. Kelly
Department of Radiology, Weill Cornell Medicine, New York, NY
1 shared publication
Latest Publications
- Open Access
- 21 October 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (23)
FAP PET identifies earlycardiac molecular changesinduced by doxorubicin chemotherapy
Anthracycline chemotherapy, widely used in cancer treatment, poses a significant risk of cardiotoxicity that results in functional decline. Current diagnostic methods poorly predict cardiotoxicity because they do not detect early damage that precedes dysfunction. Positron emission tomography (PET) is well suited to address this need when coupled with suitable imaging biomarkers. We used PET to evaluate cardiac molecular changes in male C57BL/6J mice exposed to doxorubicin (DOX). These mice initially developed cardiac atrophy, experienced functional deficits within 10 weeks of treatment, and developed cardiac fibrosis by 16 weeks. Elevated cardiac uptake of [ 68 Ga]Ga-FAPI-04, a PET tracer targeting fibroblast activation protein α (FAP), was evident by 2 weeks and preceded the onset of functional deficits. Cardiac PET signal correlated with FAP expression and activity as well as other canonical indicators of cardiac remodeling. By contrast, cardiac uptake of [ 18 F]DPA-714 and [ 18 F]MFBG, which target translocator protein 18 kDa and the norepinephrine transporter, respectively, did not differ between the DOX animals and their controls. These findings identify FAP as an early imaging biomarker for DOX-induced cardiac remodeling in males and support the use of FAP PET imaging to detect some cancer patients at risk for treatment-related myocardial damage before cardiac function declines.
- 21 October 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (23)
Open AccessFAP PET identifies earlycardiac molecular changesinduced by doxorubicin chemotherapy
Anthracycline chemotherapy, widely used in cancer treatment, poses a significant risk of cardiotoxicity that results in functional decline. Current diagnostic methods poorly predict cardiotoxicity because they do not detect early damage that precedes dysfunction. Positron emission tomography (PET) is well suited to address this need when coupled with suitable imaging biomarkers. We used PET to evaluate cardiac molecular changes in male C57BL/6J mice exposed to doxorubicin (DOX). These mice initially developed cardiac atrophy, experienced functional deficits within 10 weeks of treatment, and developed cardiac fibrosis by 16 weeks. Elevated cardiac uptake of [ 68 Ga]Ga-FAPI-04, a PET tracer targeting fibroblast activation protein α (FAP), was evident by 2 weeks and preceded the onset of functional deficits. Cardiac PET signal correlated with FAP expression and activity as well as other canonical indicators of cardiac remodeling. By contrast, cardiac uptake of [ 18 F]DPA-714 and [ 18 F]MFBG, which target translocator protein 18 kDa and the norepinephrine transporter, respectively, did not differ between the DOX animals and their controls. These findings identify FAP as an early imaging biomarker for DOX-induced cardiac remodeling in males and support the use of FAP PET imaging to detect some cancer patients at risk for treatment-related myocardial damage before cardiac function declines.
- 2 May 2019
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (9)
Pressure overload leads to coronary plaque formation, progression, and myocardial events in ApoE–/– mice
Hypercholesterolemia and hypertension are two major risk factors for coronary artery diseases, which remain the major cause of mortality in the industrialized world. Current animal models of atherosclerosis do not recapitulate coronary plaque disruption, thrombosis, and myocardial infarction occurring in humans. Recently, we demonstrated that exposure of the heart to high pressure, by transverse aortic constriction (TAC), induced coronary lesions in ApoE –/– mice on chow diet. The aim of this study was to characterize the magnitude and location of coronary lesions in ApoE –/– mice after TAC and to assess the susceptibility of coronary plaque to disruption, leading to myocardial events. Here, we describe a reliable pathological condition in mice characterized by the development of coronary lesions and its progression, leading to myocardial infarction; this model better recapitulates human disease. Following TAC surgery, about 90% of ApoE –/– mice developed coronary lesions, especially in the left anterior descending artery, with 59% of the mice manifesting a different magnitude of LAD stenosis. Myocardial events, identified in 74% of the mice, were mainly due to coronary plaque thrombosis and occlusion. That TAC-induced development and progression of coronary lesions in ApoE –/– mice, leading to myocardial events, represents a potentially novel and important tool to investigate the development of coronary lesions and its sequelae in a setting that better resemble human conditions.
- 2 May 2019
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (9)
Pressure overload leads to coronary plaque formation, progression, and myocardial events in ApoE–/– mice
Hypercholesterolemia and hypertension are two major risk factors for coronary artery diseases, which remain the major cause of mortality in the industrialized world. Current animal models of atherosclerosis do not recapitulate coronary plaque disruption, thrombosis, and myocardial infarction occurring in humans. Recently, we demonstrated that exposure of the heart to high pressure, by transverse aortic constriction (TAC), induced coronary lesions in ApoE –/– mice on chow diet. The aim of this study was to characterize the magnitude and location of coronary lesions in ApoE –/– mice after TAC and to assess the susceptibility of coronary plaque to disruption, leading to myocardial events. Here, we describe a reliable pathological condition in mice characterized by the development of coronary lesions and its progression, leading to myocardial infarction; this model better recapitulates human disease. Following TAC surgery, about 90% of ApoE –/– mice developed coronary lesions, especially in the left anterior descending artery, with 59% of the mice manifesting a different magnitude of LAD stenosis. Myocardial events, identified in 74% of the mice, were mainly due to coronary plaque thrombosis and occlusion. That TAC-induced development and progression of coronary lesions in ApoE –/– mice, leading to myocardial events, represents a potentially novel and important tool to investigate the development of coronary lesions and its sequelae in a setting that better resemble human conditions.
- Open Access
- 26 February 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 562181
Pressure overload leads to coronary plaque formation, progression and myocardial events in ApoE-/- mice
Hypercholesterolemia and hypertension are two major risk factors for coronary artery diseases, which remain the major cause of mortality in the industrialized world. Current animal models of atherosclerosis do not recapitulate coronary plaque disruption, thrombosis and myocardial infarction occurring in human. Recently, we demonstrated that exposure of the heart to high pressure, by transverse aortic constriction (TAC), induced coronary lesions in ApoE-/- mice on chow diet.The aim of this study was to characterize the magnitude and location of coronary lesions in ApoE-/- mice post-TAC, and to assess the susceptibility of coronary plaque to disruption, leading to myocardial events.Here we describe a reliable pathological condition in mice characterized by the development of coronary lesions and its progression leading to myocardial infarction, which better recapitulate human disease. Following TAC surgery, about 90% of ApoE-/- mice develop coronary lesions, especially in the left anterior descending artery, with 59% of the mice manifesting different magnitude of LAD stenosis. Myocardial events, identified in 74% of the mice, were mainly due to coronary plaque thrombosis and occlusion.That TAC induces the development and progression of coronary lesions in ApoE-/- mice leading to myocardial events represents a novel and important tool to investigate the development of coronary lesions and its sequelae in a setting that better resemble human conditions.
- 26 February 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 562181
Open AccessPressure overload leads to coronary plaque formation, progression and myocardial events in ApoE-/- mice
Hypercholesterolemia and hypertension are two major risk factors for coronary artery diseases, which remain the major cause of mortality in the industrialized world. Current animal models of atherosclerosis do not recapitulate coronary plaque disruption, thrombosis and myocardial infarction occurring in human. Recently, we demonstrated that exposure of the heart to high pressure, by transverse aortic constriction (TAC), induced coronary lesions in ApoE-/- mice on chow diet.The aim of this study was to characterize the magnitude and location of coronary lesions in ApoE-/- mice post-TAC, and to assess the susceptibility of coronary plaque to disruption, leading to myocardial events.Here we describe a reliable pathological condition in mice characterized by the development of coronary lesions and its progression leading to myocardial infarction, which better recapitulate human disease. Following TAC surgery, about 90% of ApoE-/- mice develop coronary lesions, especially in the left anterior descending artery, with 59% of the mice manifesting different magnitude of LAD stenosis. Myocardial events, identified in 74% of the mice, were mainly due to coronary plaque thrombosis and occlusion.That TAC induces the development and progression of coronary lesions in ApoE-/- mice leading to myocardial events represents a novel and important tool to investigate the development of coronary lesions and its sequelae in a setting that better resemble human conditions.